CD44 and breast cancer: Notably, Å6 inhibited the migration of a subset of ovarian and breast cancer cell lines in vitro by inducing high adhesion of the CD44-expressing cells to an HA substrate and altering CD44 conformation (79), obviously locking the cells to substrates of HA, abundantly found, e.g., in LNs.